176 related articles for article (PubMed ID: 35728876)
1. Cancer cells resist antibody-mediated destruction by neutrophils through activation of the exocyst complex.
van Rees DJ; Bouti P; Klein B; Verkuijlen PJH; van Houdt M; Schornagel K; Tool ATJ; Venet D; Sotiriou C; El-Abed S; Izquierdo M; Guillaume S; Saura C; Di Cosimo S; Huober J; Roylance R; Kim SB; Kuijpers TW; van Bruggen R; van den Berg TK; Matlung HL
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35728876
[TBL] [Abstract][Full Text] [Related]
2. G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment.
Martinez Sanz P; van Rees DJ; van Zogchel LMJ; Klein B; Bouti P; Olsman H; Schornagel K; Kok I; Sunak A; Leeuwenburg K; Timmerman I; Dierselhuis MP; Kholosy WM; Molenaar JJ; van Bruggen R; van den Berg TK; Kuijpers TW; Matlung HL; Tytgat GAM; Franke K
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34049929
[TBL] [Abstract][Full Text] [Related]
3. Kindlin3-Dependent CD11b/CD18-Integrin Activation Is Required for Potentiation of Neutrophil Cytotoxicity by CD47-SIRPα Checkpoint Disruption.
Bouti P; Zhao XW; Verkuijlen PJJH; Tool ATJ; van Houdt M; Köker N; Köker MY; Keskin O; Akbayram S; van Bruggen R; Kuijpers TW; Matlung HL; van den Berg TK
Cancer Immunol Res; 2021 Feb; 9(2):147-155. PubMed ID: 33355195
[TBL] [Abstract][Full Text] [Related]
4. Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis.
Matlung HL; Babes L; Zhao XW; van Houdt M; Treffers LW; van Rees DJ; Franke K; Schornagel K; Verkuijlen P; Janssen H; Halonen P; Lieftink C; Beijersbergen RL; Leusen JHW; Boelens JJ; Kuhnle I; van der Werff Ten Bosch J; Seeger K; Rutella S; Pagliara D; Matozaki T; Suzuki E; Menke-van der Houven van Oordt CW; van Bruggen R; Roos D; van Lier RAW; Kuijpers TW; Kubes P; van den Berg TK
Cell Rep; 2018 Jun; 23(13):3946-3959.e6. PubMed ID: 29949776
[TBL] [Abstract][Full Text] [Related]
5. FcγRIIIb Restricts Antibody-Dependent Destruction of Cancer Cells by Human Neutrophils.
Treffers LW; van Houdt M; Bruggeman CW; Heineke MH; Zhao XW; van der Heijden J; Nagelkerke SQ; Verkuijlen PJJH; Geissler J; Lissenberg-Thunnissen S; Valerius T; Peipp M; Franke K; van Bruggen R; Kuijpers TW; van Egmond M; Vidarsson G; Matlung HL; van den Berg TK
Front Immunol; 2018; 9():3124. PubMed ID: 30761158
[TBL] [Abstract][Full Text] [Related]
6. Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients.
Suzuki E; Kataoka TR; Hirata M; Kawaguchi K; Nishie M; Haga H; Toi M
BMC Cancer; 2015 Feb; 15():39. PubMed ID: 25655677
[TBL] [Abstract][Full Text] [Related]
7. Sodium stibogluconate and CD47-SIRPα blockade overcome resistance of anti-CD20-opsonized B cells to neutrophil killing.
van Rees DJ; Brinkhaus M; Klein B; Verkuijlen P; Tool ATJ; Schornagel K; Treffers LW; van Houdt M; Kater AP; Vidarsson G; Gennery AR; Kuijpers TW; van Bruggen R; Matlung HL; van den Berg TK
Blood Adv; 2022 Apr; 6(7):2156-2166. PubMed ID: 34942000
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation of human neutrophil Fcγ receptors and SIRPα in antibody-dependent cellular cytotoxicity towards cancer cells.
Treffers LW; Zhao XW; van der Heijden J; Nagelkerke SQ; van Rees DJ; Gonzalez P; Geissler J; Verkuijlen P; van Houdt M; de Boer M; Kuijpers TW; van den Berg TK; Matlung HL
Eur J Immunol; 2018 Feb; 48(2):344-354. PubMed ID: 28952147
[TBL] [Abstract][Full Text] [Related]
9. SIGLEC-5/14 Inhibits CD11b/CD18 Integrin Activation and Neutrophil-Mediated Tumor Cell Cytotoxicity.
Bouti P; Blans C; Klein BJAM; Shome D; Nadafi R; Van Houdt M; Schornagel K; Verkuijlen PJJH; Roos V; Reijmers RM; Van Bruggen R; Kuijpers TW; Matlung HL
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38138970
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu.
Cooley S; Burns LJ; Repka T; Miller JS
Exp Hematol; 1999 Oct; 27(10):1533-41. PubMed ID: 10517495
[TBL] [Abstract][Full Text] [Related]
11. Neutrophils as immune effector cells in antibody therapy in cancer.
Behrens LM; van Egmond M; van den Berg TK
Immunol Rev; 2023 Mar; 314(1):280-301. PubMed ID: 36331258
[TBL] [Abstract][Full Text] [Related]
12. Macrophage-Mediated Trogocytosis Leads to Death of Antibody-Opsonized Tumor Cells.
Velmurugan R; Challa DK; Ram S; Ober RJ; Ward ES
Mol Cancer Ther; 2016 Aug; 15(8):1879-89. PubMed ID: 27226489
[TBL] [Abstract][Full Text] [Related]
13. Antibody-dependent cellular cytotoxicity-inducing antibodies enhance the natural killer cell anti-cancer response against patient-derived pancreatic cancer organoids.
Beelen NA; Aberle MR; Bruno V; Olde Damink SWM; Bos GMJ; Rensen SS; Wieten L
Front Immunol; 2023; 14():1133796. PubMed ID: 37520563
[TBL] [Abstract][Full Text] [Related]
14. Calicum microdomains form within neutrophils at the neutrophil-tumor cell synapse: role in antibody-dependent target cell apoptosis.
Clark AJ; Diamond M; Elfline M; Petty HR
Cancer Immunol Immunother; 2010 Jan; 59(1):149-59. PubMed ID: 19593564
[TBL] [Abstract][Full Text] [Related]
15. Effects of HER Family-targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer.
Collins DM; Madden SF; Gaynor N; AlSultan D; Le Gal M; Eustace AJ; Gately KA; Hughes C; Davies AM; Mahgoub T; Ballot J; Toomey S; O'Connor DP; Gallagher WM; Holmes FA; Espina V; Liotta L; Hennessy BT; O'Byrne KJ; Hasmann M; Bossenmaier B; O'Donovan N; Crown J
Clin Cancer Res; 2021 Feb; 27(3):807-818. PubMed ID: 33122343
[TBL] [Abstract][Full Text] [Related]
16. Targeting the CD47-SIRPα Innate Immune Checkpoint to Potentiate Antibody Therapy in Cancer by Neutrophils.
Behrens LM; van den Berg TK; van Egmond M
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884427
[TBL] [Abstract][Full Text] [Related]
17. Evaluating Antibody-Dependent Cell-Mediated Cytotoxicity by Flow Cytometry.
van der Haar Àvila I; Marmol P; Cany J; Kiessling R; Pico de Coaña Y
Methods Mol Biol; 2019; 1913():181-194. PubMed ID: 30666607
[TBL] [Abstract][Full Text] [Related]
18. Canine non-B, non-T NK lymphocytes have a potential antibody-dependent cellular cytotoxicity function against antibody-coated tumor cells.
Kim Y; Lee SH; Kim CJ; Lee JJ; Yu D; Ahn S; Shin DJ; Kim SK
BMC Vet Res; 2019 Oct; 15(1):339. PubMed ID: 31610784
[TBL] [Abstract][Full Text] [Related]
19. Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG.
Brandsma AM; Bondza S; Evers M; Koutstaal R; Nederend M; Jansen JHM; Rösner T; Valerius T; Leusen JHW; Ten Broeke T
Front Immunol; 2019; 10():704. PubMed ID: 31031746
[TBL] [Abstract][Full Text] [Related]
20. Human Tumor-Associated Macrophages and Neutrophils Regulate Antitumor Antibody Efficacy through Lethal and Sublethal Trogocytosis.
Singhal S; Rao AS; Stadanlick J; Bruns K; Sullivan NT; Bermudez A; Honig-Frand A; Krouse R; Arambepola S; Guo E; Moon EK; Georgiou G; Valerius T; Albelda SM; Eruslanov EB
Cancer Res; 2024 Apr; 84(7):1029-1047. PubMed ID: 38270915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
